Zhende Medical Co., Ltd.
SSE:603301.SS
20.83 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 397.211 | 198.399 | 703.012 | 720.947 | 2,971.9 | 176.585 | 129.879 | 122.115 | 82.883 | 79.249 | 21.775 |
| Depreciation & Amortization
| 246.523 | 242.969 | 194.277 | 141.967 | 78.568 | 65.295 | 61.505 | 58.632 | 47.819 | 40.955 | 38.078 |
| Deferred Income Tax
| 0 | 0 | -6.206 | -16.226 | -18.958 | -0.065 | 0.933 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 19.606 | 14.529 | 0 | 0 | 0 | 0 | 10.24 | 8.447 | 0 |
| Change In Working Capital
| -152.003 | -270.126 | 145.027 | -114.405 | -150.916 | -77.2 | -198.821 | -26.613 | -21.492 | 4.035 | 0 |
| Accounts Receivables
| -255.368 | 307.448 | -127.952 | 49.708 | -468.072 | -150.941 | -81.944 | -12.777 | -5.089 | -4.389 | 0 |
| Inventory
| -10.442 | -12.697 | -228.707 | 279.073 | -659.324 | -47.357 | -173.925 | -0.987 | -69.26 | 20.102 | 0 |
| Accounts Payables
| 0 | -536.273 | 507.892 | -426.959 | 995.437 | 121.164 | 56.116 | 14.288 | 16.184 | -34.874 | 0 |
| Other Working Capital
| 113.806 | -28.603 | -6.206 | -16.226 | -18.958 | -0.065 | -24.895 | -25.626 | 47.768 | -16.067 | 0 |
| Other Non Cash Items
| -30.588 | 280.865 | 203.728 | 70.816 | 221.288 | 33.083 | 27.683 | 28.21 | 29.364 | 18.46 | -21.775 |
| Operating Cash Flow
| 461.143 | 452.107 | 1,246.045 | 817.629 | 3,120.84 | 197.763 | 20.246 | 182.344 | 138.574 | 142.699 | 83.627 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -769.69 | -599.235 | -754.12 | -695.466 | -1,092.788 | -273.788 | -226.702 | -144.447 | -159.227 | -23.13 | -57.934 |
| Acquisitions Net
| -48.66 | -311.912 | -25.521 | -545.536 | -92.33 | -33.202 | -16.319 | -3 | -3 | -48.667 | -14.418 |
| Purchases Of Investments
| -1,358.382 | -569.871 | -302.773 | -575.652 | -1,314 | -233 | -714 | -1.05 | -160.712 | -331.2 | -4.73 |
| Sales Maturities Of Investments
| 1,283.534 | 410.624 | 86.453 | 1,020.932 | 872.077 | 217.566 | 719.542 | 3.077 | 348.865 | 183.56 | 0.273 |
| Other Investing Activites
| 125.211 | 12.542 | 3.169 | 241.305 | -163.135 | 3.34 | 75.853 | 9.02 | 24.229 | 86.067 | 17.043 |
| Investing Cash Flow
| -767.987 | -1,057.854 | -992.792 | -554.417 | -1,790.176 | -319.084 | -161.626 | -136.4 | 50.154 | -133.37 | -59.766 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 24.26 | 0.11 | -136.11 | 352 | 6.795 | 448.885 | -61.139 | -15.245 | -60.09 | -224.9 | 36.8 |
| Common Stock Issued
| 0 | 0 | 113.152 | 133.383 | 0 | 0 | -21.968 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -113.152 | -133.383 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -159.395 | -423.716 | -136.323 | -522.571 | -60.2 | -35 | -21.016 | -21.358 | -22.627 | -37.787 | -60.064 |
| Other Financing Activities
| -34.296 | 0.323 | 756.361 | -75.612 | -206.146 | 14.265 | 453.4 | 19.9 | -183.093 | 308.98 | -4.071 |
| Financing Cash Flow
| -169.431 | -423.284 | 455.998 | -379.566 | -277.659 | 428.15 | 349.277 | -16.703 | -265.81 | 46.293 | -27.335 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 21.205 | 12.815 | -3.699 | -38.294 | -96.658 | 4.36 | -13.368 | -6.903 | 9.85 | 13.504 | -2.823 |
| Net Change In Cash
| -455.071 | -1,016.215 | 705.551 | -154.648 | 956.347 | 311.189 | 194.529 | 22.338 | -67.232 | 69.127 | -6.297 |
| Cash At End Of Period
| 589.333 | 1,044.404 | 2,060.619 | 1,355.068 | 1,509.716 | 553.368 | 242.179 | 47.65 | 25.313 | 92.544 | 23.417 |